Publication of List of Manufacturers Revoked from Licensing for the Manufacture of Therapeutic Goods - INova Pharmaceuticals Australia Pty Limited

Overview

The Therapeutic Goods Act 1989 was enacted to provide a regulatory framework for therapeutic goods in Australia, ensuring they are of acceptable quality, safety, and efficacy. This Act is administered by the Therapeutic Goods Administration (TGA), an agency of the Australian Government Department of Health. The revocation of a manufacturer's licence under the Therapeutic Goods Act serves to address situations where a manufacturer no longer meets the necessary standards or requirements for the production of therapeutic goods. The revocation process is intended to protect public health and safety by removing from the market products that may not comply with regulatory standards. In this instance, the revocation of Inova Pharmaceuticals Australia Pty Limited's licence, as announced by the Delegate of the Secretary, underscores the TGA's commitment to maintaining rigorous oversight and quality control within the therapeutic goods industry.

Scope and Application

The Therapeutic Goods Act 1989 applies to any person or entity involved in the manufacture, importation, supply, or evaluation of therapeutic goods within Australia. This includes pharmaceutical products, medical devices, blood and blood components, and tissues. The Act extends its reach to all states and territories across the Commonwealth of Australia, ensuring a uniform regulatory framework for therapeutic goods throughout the nation. Certain activities, such as the sale of therapeutic goods by retail pharmacists or the supply of therapeutic goods by healthcare professionals in the course of professional practice, are often excluded from the scope of this legislation to avoid undue regulatory burdens on everyday medical practice. The Act may also impose specific thresholds and criteria, such as the need for a manufacturing licence for entities involved in the production of therapeutic goods. The application and enforcement of the Act can be further refined through subordinate instruments, which may introduce additional regulations or guidelines to address emerging issues or technologies in the therapeutic goods sector.

Key Provisions

The Therapeutic Goods Act 1989 includes a provision (section 41) that allows for the revocation of a manufacturer's licence. Section 41(1)(d) specifically provides the Secretary with the authority to revoke a licence in writing, either on their own initiative or at the request of the manufacturer. This particular Gazette notice (C2013G01446) pertains to the revocation of Licence No 352 (MI-12112004-LI-000160-1) held by inova Pharmaceuticals AUSTRALIA PTY LIMITED, a company located at 9-15 Chilvers Road, Thornleigh NSW 2120. The revocation was executed at the manufacturer's request. Under the Act, parties or entities governed by it must comply with the conditions set forth in their licences, ensuring adherence to quality and safety standards for therapeutic goods. Manufacturers must maintain the integrity of their manufacturing processes, adhere to Good Manufacturing Practice (GMP) standards, and ensure that the therapeutic goods they produce meet the required specifications and safety standards. If a manufacturer requests a revocation, they must follow the formal process outlined in the Act to ensure the licence is revoked properly and legally. Failure to comply with the provisions of the Therapeutic Goods Act 1989 can result in severe consequences. Offences under the Act can include the manufacture or supply of therapeutic goods that do not meet required standards, misleading or deceptive conduct, or providing false or misleading information. The Act outlines both civil and criminal penalties for breaches. For instance, under section 14, a person who contravenes a provision of the Act may be liable to a civil penalty of up to $1,650,000 for a corporation and $330,000 for an individual, as well as potential criminal penalties. The maximum penalties can vary depending on the severity of the offence and are determined by the courts. These consequences underscore the importance of compliance with the Act's provisions for all involved parties.